MarineMax
HZO NYSE Specialty Stores Financials FY2016βFY2025
MarineMax's revenue fell 5.0% to $2.3 billion in fiscal 2025. Its operating margin was 1.5%, down from 5.3% a year earlier. Free cash flow was $12 million. It paid out $27 million in dividends and buybacks, 230% of free cash flow. The diluted share count fell 4.2%.
What MarineMax does
No business description yet.
- Legal name
- MARINEMAX INC
- Fiscal year ends
- September 30, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-25-284680
0001057060
Revenue and margins
MarineMax had $2.3B of revenue in fiscal 2025, down 5.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $11.9M in fiscal 2025, 0.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
MarineMax returned $27.5M to shareholders in fiscal 2025, 230% of free cash flow. The diluted share count fell 4.2%.
Value MarineMax yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$939M and divides by 22.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today β Β· peers 15.0x Β· sector 17.8x.
Balance sheet
Cash, debt and the ratios that show how comfortably MarineMax can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $222M | $228M | $202M | $224M | $170M |
| Debt incl. finance leases | $75.6M | $181M | $962M | $1.1B | $1.1B |
| Net debt / EBITDA | β0.7x | β0.2x | 3.1x | 5.1x | 11.3x |
| Debt / equity | 0.1x | 0.2x | 1.1x | 1.1x | 1.2x |
| Interest coverage | 57.2x | 80.8x | 3.8x | 1.7x | 0.5x |
| Current ratio | 2.1x | 1.8x | 1.3x | 1.2x | 1.2x |
| Quick ratio | 1.1x | 0.7x | 0.4x | 0.3x | 0.3x |
| Total assets | $1.0B | $1.4B | $2.4B | $2.6B | $2.5B |
| Total liabilities | $413M | $570M | $1.5B | $1.6B | $1.5B |
| Shareholders' equity | $595M | $783M | $916M | $976M | $937M |
| Net debt (β = net cash) | β$147M | β$47.6M | $761M | $876M | $939M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 1 / 9 | 2 / 9 | 5 / 9 |
| Accruals ratio | 17.6% | 2.5% | β4.1% |
| Altman Z'' | 2.94 | 2.46 | 2.25 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| MarineMax HZO | $1.2B | β5.0% | 1.5% | 0.5% | 1.4% | β | 5 | |
| National Vision EYE | $1.5B | 9.0% | 3.0% | 3.7% | 3.9% | 30.6x | 7 | Compare β |
| Sally Beauty SBH | $1.7B | β0.4% | 8.9% | 4.7% | 16.1% | 9.1x | 8 | Compare β |
| Five Below FIVE | $12.4B | 22.9% | 9.6% | 8.6% | 26.9% | 20.0x | 7 | Compare β |
| Academy Sports + Outdoors ASO | $3.8B | 2.0% | 8.5% | 3.7% | 17.6% | 10.1x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $942M | $1.1B | $1.2B | $1.2B | $1.5B | $2.1B | $2.3B | $2.4B | $2.4B | $2.3B |
| Gross profit | $226M | $265M | $298M | $323M | $399M | $659M | $806M | $835M | $801M | $750M |
| Operating income | $40.3M | $45.3M | $63.2M | $60.5M | $107M | $210M | $265M | $201M | $128M | $34.0M |
| Interest expense | $5.5M | $7.5M | $9.9M | $11.6M | $9.3M | $3.7M | $3.3M | $53.4M | $73.9M | $71.2M |
| Pretax income | $34.8M | $37.8M | $53.3M | $49.0M | $97.4M | $206M | $262M | $147M | $54.3M | β$37.1M |
| Income tax | $12.2M | $14.3M | $14.0M | $13.0M | $22.8M | $50.8M | $63.9M | $38.0M | $15.6M | β$6.4M |
| Net income | $22.6M | $23.5M | $39.3M | $36.0M | $74.6M | $155M | $198M | $109M | $38.1M | β$31.6M |
| Diluted EPS | $0.91 | $0.95 | $1.71 | $1.57 | $3.37 | $6.78 | $8.84 | $4.87 | $1.65 | β$1.43 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $22.9M | $4.7M | $70.4M | β$12.4M | $305M | $374M | $76.6M | β$222M | β$25.7M | $72.8M |
| Capital expenditure | $12.9M | $14.4M | $13.8M | $17.1M | $12.8M | $26.1M | $58.5M | $65.4M | $60.4M | $60.9M |
| Free cash flow | $10.0M | β$9.6M | $56.6M | β$29.5M | $292M | $348M | $18.1M | β$288M | β$86.1M | $11.9M |
| Depreciation and amortization | $8.0M | $9.4M | $10.7M | $11.6M | $12.8M | $15.6M | $19.4M | $41.0M | $44.5M | $49.3M |
| Stock-based compensation | $4.2M | $6.2M | $6.2M | $6.5M | $7.5M | $9.7M | $16.0M | $21.7M | $24.0M | $19.4M |
| Acquisitions | $17.1M | $18.7M | $10.5M | $40.7M | $19.8M | $134M | $83.2M | $517M | $22.0M | $10.5M |
| Share buybacks | $5.5M | $42.7M | $0.7M | $27.7M | $0.6M | $23.8M | $21.3M | $0.0M | $2.1M | $27.5M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $5.5M | $42.7M | $0.7M | $27.7M | $0.6M | $23.8M | $21.3M | $0.0M | $2.1M | $27.5M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $38.6M | $42.0M | $48.8M | $38.5M | $156M | $222M | $228M | $202M | $224M | $170M |
| Total debt | $167M | $254M | $213M | $312M | $152M | $75.6M | $181M | $962M | $1.1B | $1.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $391M | $474M | $465M | $569M | $503M | $518M | $754M | $1.1B | $1.3B | $1.2B |
| Current liabilities | $232M | $335M | $286M | $413M | $273M | $251M | $413M | $847M | $1.1B | $985M |
| Inventory | $322M | $401M | $377M | $478M | $298M | $231M | $454M | $813M | $907M | $867M |
| Property and equipment, net | $121M | $127M | $139M | $144M | $142M | $176M | $246M | $528M | $533M | $553M |
| Total assets | $547M | $640M | $641M | $784M | $775M | $1.0B | $1.4B | $2.4B | $2.6B | $2.5B |
| Total liabilities | $234M | $338M | $287M | $415M | $320M | $413M | $570M | $1.5B | $1.6B | $1.5B |
| Shareholders' equity | $313M | $302M | $353M | $369M | $455M | $595M | $783M | $916M | $976M | $937M |
| Margins | ||||||||||
| Gross margin | 24.0% | 25.2% | 25.3% | 26.1% | 26.4% | 32.0% | 34.9% | 34.9% | 33.0% | 32.5% |
| Operating margin | 4.3% | 4.3% | 5.4% | 4.9% | 7.1% | 10.2% | 11.5% | 8.4% | 5.3% | 1.5% |
| EBITDA margin | 5.1% | 5.2% | 6.3% | 5.8% | 7.9% | 10.9% | 12.3% | 10.1% | 7.1% | 3.6% |
| Net margin | 2.4% | 2.2% | 3.3% | 2.9% | 4.9% | 7.5% | 8.6% | 4.6% | 1.6% | β1.4% |
| FCF margin | 1.1% | β0.9% | 4.8% | β2.4% | 19.3% | 16.9% | 0.8% | β12.0% | β3.5% | 0.5% |
| Returns | ||||||||||
| Return on capital | 6.3% | 5.9% | 9.0% | 7.7% | 14.9% | 35.0% | 33.9% | 12.4% | 5.2% | 1.4% |
| Return on capital employed | 13.4% | 14.6% | 19.2% | 16.7% | 24.4% | 33.3% | 31.3% | 16.0% | 8.3% | 2.3% |
| Return on equity | 7.6% | 7.7% | 12.0% | 10.0% | 18.1% | 29.5% | 28.7% | 12.9% | 4.0% | β3.3% |
| Return on assets | 4.5% | 4.0% | 6.1% | 5.1% | 9.6% | 17.4% | 16.8% | 5.8% | 1.5% | β1.3% |
| Growth | ||||||||||
| Revenue growth | 25.4% | 11.7% | 11.9% | 5.1% | 22.0% | 36.7% | 11.9% | 3.8% | 1.5% | β5.0% |
| Net income growth | β53.2% | 4.3% | 67.0% | β8.5% | 107.4% | 107.7% | 27.8% | β44.8% | β65.2% | β183.1% |
| EPS growth | β52.6% | 4.4% | 80.0% | β8.2% | 114.7% | 101.2% | 30.4% | β44.9% | β66.1% | β186.7% |
| FCF growth | β | β196.7% | β | β152.1% | β | 19.2% | β94.8% | β1,685.8% | β | β |
| Share count change | β1.1% | β0.6% | β6.7% | β0.7% | β3.3% | 3.3% | β2.0% | 0.1% | 2.6% | β4.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.7x | 3.9x | 2.2x | 3.8x | β0.0x | β0.7x | β0.2x | 3.1x | 5.1x | 11.3x |
| Debt / equity | 0.5x | 0.8x | 0.6x | 0.9x | 0.3x | 0.1x | 0.2x | 1.1x | 1.1x | 1.2x |
| Interest coverage | 7.4x | 6.1x | 6.4x | 5.2x | 11.5x | 57.2x | 80.8x | 3.8x | 1.7x | 0.5x |
| Current ratio | 1.7x | 1.4x | 1.6x | 1.4x | 1.9x | 2.1x | 1.8x | 1.3x | 1.2x | 1.2x |
| Quick ratio | 0.3x | 0.2x | 0.3x | 0.2x | 0.8x | 1.1x | 0.7x | 0.4x | 0.3x | 0.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.4% | 1.4% | 1.2% | 1.4% | 0.9% | 1.3% | 2.5% | 2.7% | 2.5% | 2.6% |
| Stock comp / revenue | 0.5% | 0.6% | 0.5% | 0.5% | 0.5% | 0.5% | 0.7% | 0.9% | 1.0% | 0.8% |
| Payouts / FCF | 55.6% | β | 1.2% | β | 0.2% | 6.8% | 117.4% | β | β | 230.1% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 4.0 | 8.0 | 4.0 | 8.0 | 8.0 | 4.0 | 1.0 | 2.0 | 5.0 |
| Altman Z'' | 4.4 | 3.5 | 4.6 | 3.6 | 5.5 | 6.0 | 5.9 | 2.9 | 2.5 | 2.3 |
| Accruals ratio | β0.1% | 3.2% | β4.9% | 6.8% | β29.5% | β24.6% | 10.3% | 17.6% | 2.5% | β4.1% |
Source: SEC EDGAR XBRL filings (CIK 0001057060). Data updated October 19, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.